Immatics Results Presentation Deck
October 2022, 25 slides
  1. Immatics
  2. Related Decks
  3. Results Presentation Decks
pes a targeting | Immatics
forward looking statement | Immatics
tumor target cut melanoma | Immatics
phase design | Immatics
phase design | Immatics
moving from phase a to phase | Immatics
interim update phase phase cohort a key take limited number of confirmation of all objective | Immatics
patient and product characteristics | Immatics
tolerability profile most frequent adverse events | Immatics
frequency of observed objective responses | Immatics
best overall response pied bod ads | Immatics
responses over time | Immatics
translational data consistent with clinical outcomes a | Immatics
expression in tumors from screened patients i | Immatics
moving from phase a to phase | Immatics
has the potential to reach a large patient population | Immatics
conclusions | Immatics
comprehensive strategy | Immatics
we are immensely grateful to the patients their families and the investigators at the clinical sites | Immatics
delivering the power of cells to cancer patients | Immatics
product manufacturing | Immatics
tolerability profile all grade adverse events voe | Immatics
focus on melanoma patients a melanoma | Immatics
expression in tumors from screened patients | Immatics
expression data | Immatics
See More
Immatics
Results Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Tumor
Melanoma
Monotherapy
Solid tumor
Recent decks by Immatics
Investor Presentation
November 2023
See all presentations by Immatics (2 decks)
Related decks
Alkermes
Investor Presentation
October 2023
Alkermes
Investor Day
March 2021
BioAtla
Investor Presentation
January 2024
Alkermes
Results
June 2022
Alkermes
Results
June 2021
TScan Therapeutics
IPO
July 2021
Erasca
Investor Presentation
August 2023
BioNTech
Results
May 2021
Recent decks by Immatics
See all presentations (2 decks)
Investor Presentation
November 2023
Alkermes
Investor Presentation
October 2023
Alkermes
Investor Day
March 2021
BioAtla
Investor Presentation
January 2024
Alkermes
Results
June 2022
Alkermes
Results
June 2021
TScan Therapeutics
IPO
July 2021
Erasca
Investor Presentation
August 2023
BioNTech
Results
May 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights